Breast cancer genetics: Family history, heterogeneity, molecular genetic diagnosis, and genetic counseling

Current Problems in Cancer

Volumn 20, Issue 6, 1996, Pages 329-365

  Lynch, Henry T ^a   Lynch, Jane F ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST TUMOR; FEMALE; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENETICS; HUMAN; MALE; MIDDLE AGED; ONSET AGE; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; AGE OF ONSET; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC COUNSELING; GENETIC HETEROGENEITY; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0344024149     PISSN: 01470272     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0147-0272(96)80010-9     Document Type: Article

References (67)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;65:5-27.
2. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset breast cancer to chromosome 17q21. Science 1990:250:1684-9.
3. Lynch HT, Foillett KL, Lynch PM, Albano WA, Mailliard JL, Pierson RL. Family history in an oncology clinic: implications for cancer genetics. JAMA 1979;242:1268-72.
4. David KL, Steiner-Grossman P. The potential use of tumor registry data in the recognition and prevention of hereditary and familial cancer. New York State J Med 1991;91:150-2.
5. Arvanitis ML, Jagelman DG, Fazio VN, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990;33:639-42.
6. Lynch HT, Watson P, Conway TA, et al. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch Intern Med 1993;153:1979-87.
7. Lynch HT, Lynch J, Conway T, et al. Hereditary breast cancer and family cancer syndromes. World J Surg 1994;18:21-31.
8. Lynch HT, Conway TA, Lynch JF. Phenotypic variation in hereditary breast cancer: cancer control implications. Arch Surg 1994;129:806-13.
9. Lynch HT, Krush AJ, Lemon HM, Kaplan AR, Condit PT, Bottomley RH. Tumor variation in families with breast cancer. JAMA 1972;222:1631-5.
10. Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lenoir GM. Familial breastovarian cancer locus on chromosome 17ql2-q23. Lancet 1991;388:82-3.
11. Feunteun J, Narod SA, Lynch HT, et al. A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. Am J Hum Genet 1993;52:736-42.
12. Easton DF, Bishop DT, Ford D, Crockford GP, Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:678-701.
13. Ford D, Easton DF. The genetics of breast and ovarian cancer. Br J Cancer 1995;72:805-12.
14. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1mutation carriers. Lancet 1994;343:692-5.
15. Serova O, Montagna M, Torchard D, et al. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 1996;58:42-51.
16. Shattuck-Eidens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 1995;273:535-41.
17. Castilla LH, Couch FJ, Erdos MR, et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 1994;8:387-91.
18. Friedman LS, Ostermeyer EA, Szabo CI, et al. Confirmation of BRCA 1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994;8:399-404.
19. Simard J, Tonin P, Durocher F, et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 1994;8:392-8.
20. Struewing JP, Brody LC, Erdos MR, et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 1995;57:1-7.
21. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 1995;56:265-71.
22. Gayther SA, Warren W, Mazoyer S, et al. Germline mutations of the BRCA 1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 1995;11:428-33.
23. Friedman LS, Szabo CI, Ostermeyer E A, et al. Novel inherited mutations and variable expressivity of BRCA 1 alleles, including the founder mutation 185del AG in Ashkenazi Jewish families. Am J Hum Genet 1995;57:1284-97.
24. Jensen RA, Thompson ME, Jetton TL, et al. BRCA 1 is secreted and exhibits properties of a granin. Nat Genet 1996;12:303-8.
25. Lane TF, et al. Expression of Brcal is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 1995;9:2712-22.
26. Holt JT, Thompson ME, Szabo C, et al. Growth retardation and tumour inhibition by BRCAL Nat Genet 1996;12:298-302.
27. Szabo CI, King MC. Inherited breast and ovarian cancer. Hum Mol Genet 1995;4:1811-7.
28. Malkin D, Li FP, Stron LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990;250:1233-8.
29. Gatti RA, Berkel I, Boder E, et al. Localization of an ataxia-telangiectasia gene to chromosome llq22-23. Nature 1988;366:577-80.
30. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-53.
31. Gowen LC, Johnson BL, Latour AM, Sulik KK, Koller BH. Brcal deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 1996;12:91-4.
32. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13ql2-13. Science 1994;265:1088-2090.
33. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
34. Nikolakaki E, Coffer P, Hemelsoet R, Woodgett J, Defize L. Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene 1993;8:833-40.
35. Marcus JN, Watson P, Page DL, et al. Hereditary breast cancer. Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 1996;77:697-709.
36. Lynch HT, Albano WA, Recabaren J, Lynch PM, Lynch JF, Elston RC. Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. Med Hypotheses 1981;7:1201-9.
37. Albano WA, Recabaren JA, Lynch HT, et al. Natural history of hereditary cancer of the breast and colon. Cancer 1982;50:360-3.
38. Lynch HT, Mulcahy GM, Harris RE, Guirgis HA, Lynch JF. Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma. Cancer 1978 ;41:2055-64.
39. Li FP, Fraumeni JF. Soft-tissue sarcomas, breast cancer, and other neoplasms, a familial syndrome? Ann Intern Med 1969;71:747-52.
40. Li FP, Fraumeni JF. Familial breast cancer, soft-tissue sarcomas, and other neoplasms.Ann Intern Med 1975;83:833-4.
41. Li FP, Fraumeni JF. Prospective study of a family cancer syndrome. JAMA 1982;247:2692-4.
42. Swift M. Genetic aspects of ataxia-telangiectasia. Immunodeficiency Rev 1990;2:67-81.
43. Morrell D, Cromartic E, Swift M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 1986;77:89-92.
44. Morrell D, Chase CL, Swift M. Cancers in 44 families with ataxia-telangiectasia. Cancer Genet Cytogenet 1990;50:119-23.
45. Swift M, Chase CL, Morrell D. Cancer predisposition of ataxia-telangiectasia hétérozygotes. Cancer Genet Cytogenet 1990;46:21-7.
46. Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT. The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet 1986;39:573-83.
47. Williard W, Borgen P, Bol R, Tiwari R, Osborne M. Cowden's disease. Cancer 1992;69:2969-74.
48. Lloyd KMI, Dennis M. Cowden's disease: a possible new symptom complex with multiple system involvement. Ann Intern Med 1963;58:136-42.
49. Wallon BJ, Morain WB, Baughman RD, et al. A further indication for prophylactic mastectomy. Surgery 1986;99:82-6.
50. German J. Bloom syndrome: a mendelian prototype of somatic mutational disease. Medicine 1993;72:393-406.
51. Claus EB, Risch N, Thompson WD. Age of onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961-72.
52. Peto J, Easton DF, Matthews FE, Ford D, Swerdlow AJ. Cancer mortality in relatives of women with breast cancer: the OPCS study. Int J Cancer 1996;65:275-83.
53. Easton DF, Matthews FE, Ford D, Swerdlow AJ, Peto J. Cancer mortality in relatives of women with ovarian cancer: the OPCS study. Int J Cancer 1996;65:284-94.
54. Mild Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
55. Thies U, Bockel B, Bochdalofsky V. Attitudes of neurologists, psychiatrists, and psychotherapists toward predictive testing for Huntington's disease in Germany. J Med Genet 1993;30:1023-7.
56. The World Federation of Neurology Research Group on Huntington's Disease. Presymptomatic testing for Huntington's disease: a worldwide survey. J Med Genet 1993;30:1020-2.
57. Nuffield Council on Bioethics. Genetic screening: ethical issues. London: Nuffield Foundation, 1993.
58. Andrews LB, Fullerton JE, Holtzman NA, Motulsky AG. Assessing genetic risks: implications for health and social policy. Washington (D.C.): National Academy Press, 1994.
59. Committee of the Health Council of the Netherlands. Heredity: science and society on the possibilities and limits of genetic testing and gene therapy. Hum GeneTher 1994;5:37-40.
60. American Society of Human Genetics. Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 1994;55:1-4.
61. Working Party of the Clinical Genetics Society. The genetic testing of children. J Med Genet 1994;31:785-97.
62. American College of Medical Genetics. Points to consider: ethical, legal and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 1995;57:1233-41.
63. Harper PS. Genetic testing, common diseases, and health service provision. Lancet 1995;346:1645-6.
64. Ministry of Health and Social Affairs. Biotechnology related to human beings [Abstract], 1993.
65. Lynch HT, Drouhard T, Vasen HFA, et al. Genetic counseling in a Navajo hereditary nonpolyposis colorectal cancer kindred. Cancer 1996;77:30-5.
66. Munn KE, Walker R A, Menasce L, Varley JM. Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast. Br J Cancer 1996;73:636-9.
67. Watanabe H, Sawabu N, SongiirY, et al. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis. Pancreas 1996;12:18-24.